Explore Biotech Companies

Transcend Therapeutics is a clinical-stage biotech company developing rapid-acting psychedelic-based neuroplastogens for neuropsychiatric diseases like PTSD.

📍 New York, NY

Tourmaline Bio is a late-stage clinical biotech company developing antibody therapies for inflammatory and immune diseases, acquired by Novartis.

📍 New York, NY

Synaptrix Labs develops AI-powered, non-invasive brain-computer interfaces for mobility and pain management, leveraging neuromodulation technology.

📍 New York, NY

Stelexis Therapeutics is a cancer therapeutics company that targets pre-cancerous stem cells to discover and develop transformative treatments.

📍 New York, NY

Stablix Therapeutics pioneers Targeted Protein Stabilization (TPS) and Targeted Deubiquitination Therapeutics (TDT) for unmet medical needs.

📍 New York, NY

SIGA Technologies is a commercial-stage pharmaceutical company developing small molecule drugs to prevent and treat emerging infectious diseases, with a focus on health security.

📍 New York, NY

SELLAS Life Sciences Group is a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies for indications including AML, MPM, Ovarian Cancer, and PTCL.

📍 New York, NY

Seelos Therapeutics is a clinical-stage biopharmaceutical company developing small molecule and ketamine-based therapeutics for CNS disorders and rare diseases, though it has filed for bankruptcy.

📍 New York, NY

SEED Therapeutics is a clinical-stage biotech company pioneering molecular glue degraders to treat diseases by degrading undruggable proteins.

📍 New York, NY

Rumi Scientific develops drugs and treatments for genetic diseases using brain organoids and stem cell platforms.

📍 New York, NY

Renalytix is an AI-enabled diagnostics company transforming kidney disease care with its KidneyIntelX™ bioprognosis solution.

📍 New York, NY

Recursion is a clinical-stage TechBio company using AI and automation to decode biology and accelerate drug discovery for rare diseases.

📍 New York, NY

Protara Therapeutics is a clinical-stage biotech company developing transformative cell therapies for rare diseases and cancer, including their lead program TARA-002.

📍 New York, NY

Promontory Therapeutics is a clinical-stage biopharma company developing small molecule immunotherapies for cancer, with a lead agent PT-112.

📍 New York, NY

Progyny is a leading fertility benefits management company offering IVF, preconception, family building, and women's health solutions.

📍 New York, NY

Prognos Health is a leader in clinical and genomic lab data, accelerating therapy development and providing real-world insights for precision medicine.

📍 New York, NY

Precision Neuroscience develops brain-computer interfaces (BCIs) to restore communication and independence for people with neurological illnesses.

📍 New York, NY

Pannex Therapeutics develops Panx1 blockers for cancer, neurological disorders, and chronic pain.

📍 New York, NY

Paige is a biotech company specializing in AI Pathology, developing advanced AI applications for cancer diagnostics and treatment discovery.

📍 New York, NY

Owkin is an AI biotech company using federated learning to discover treatments, optimize trials, and develop AI diagnostics.

📍 New York, NY

OverT Bio is a biotech company programming cell therapies at scale for solid tumors, focusing on novel genetic modifications and AI-powered discovery.

📍 New York, NY

Opentrons Labworks provides disruptive lab automation robots and liquid handling solutions, leveraging open-source principles to accelerate life science research and innovation.

📍 New York, NY

OnCusp Therapeutics is a clinical-stage biopharma company developing small molecules, ADCs, and bispecifics for oncology.

📍 New York, NY

OccamzRazor uses AI and machine learning to develop modality-agnostic treatments for complex brain aging diseases.

📍 New York, NY